| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,842,400 | 1,752,500 | 3,000,100 | | Cost of Revenue | 934,700 | 1,112,400 | 1,398,400 | | | Gross Profit | 907,700 | 640,100 | 1,601,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 576,900 | 373,900 | 1,160,800 | | Non Recurring | (185,900) | 18,200 | (37,100) | | Others | 111,600 | 77,500 | 267,500 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 405,100 | 170,500 | 210,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (61,500) | (43,100) | (362,300) | | Earnings Before Interest And Taxes | 324,400 | 106,300 | (222,800) | | Interest Expense | 159,700 | 229,900 | 335,100 | | Income Before Tax | 164,700 | (123,600) | (557,900) | | Income Tax Expense | (70,100) | (322,400) | 41,100 | | Minority Interest | (29,800) | (31,400) | (92,300) | | | | Net Income From Continuing Ops | 234,800 | 198,800 | (599,000) | | | Non-recurring Events | | Discontinued Operations | 17,600 | 454,600 | (26,000) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 252,400 | 653,400 | (625,000) | | Preferred Stock And Other Adjustments | (26,000) | (26,000) | (22,200) | | | Net Income Applicable To Common Shares | $226,400 | $627,400 | ($647,200) |
|
0.22% Nasdaq 
0.07 (0.39%) 
Income Statement
